1. Shen, Hengyang, Chen, Yang, Xu, Menghuan, Li, Shuwei, Fu, Zan. 2024. Cellular senescence gene TACC3 associated with colorectal cancer risk via genetic and DNA methylated alteration. In Archives of toxicology, 98, 1499-1513. doi:10.1007/s00204-024-03702-9. https://pubmed.ncbi.nlm.nih.gov/38480537/
2. Gedik, Mustafa Emre, Saatci, Ozge, Oberholtzer, Nathaniel, Mehrotra, Shikhar, Sahin, Ozgur. . Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. In Cancer research, 84, 1475-1490. doi:10.1158/0008-5472.CAN-23-2812. https://pubmed.ncbi.nlm.nih.gov/38319231/
3. Picca, Alberto, Sansone, Giulio, Santonocito, Orazio Santo, Sanson, Marc, Di Stefano, Anna Luisa. 2023. Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives. In Cancers, 15, . doi:10.3390/cancers15235555. https://pubmed.ncbi.nlm.nih.gov/38067258/
4. Yuan, Li, Liu, Zhi-Hua, Lin, Zhi-Rui, Zhong, Qian, Zeng, Mu-Sheng. . Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma. In Cancer biology & therapy, 15, 1613-21. doi:10.4161/15384047.2014.961874. https://pubmed.ncbi.nlm.nih.gov/25535896/
5. Frattini, Véronique, Pagnotta, Stefano M, Fan, Jerry J, Lasorella, Anna, Iavarone, Antonio. 2018. A metabolic function of FGFR3-TACC3 gene fusions in cancer. In Nature, 553, 222-227. doi:10.1038/nature25171. https://pubmed.ncbi.nlm.nih.gov/29323298/
6. Gött, Hanna, Uhl, Eberhard. 2022. FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma. In International journal of molecular sciences, 23, . doi:10.3390/ijms23158675. https://pubmed.ncbi.nlm.nih.gov/35955806/
7. Sarkar, Sourav, Ryan, Ellis L, Royle, Stephen J. . FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle. In Open biology, 7, . doi:10.1098/rsob.170080. https://pubmed.ncbi.nlm.nih.gov/28855393/
8. Wang, Yadong, Zhu, Jinjin, Liu, Shangwen, Liu, Yuchen, Lin, Feng. 2024. CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivo. In OncoTargets and therapy, 17, 1197-1207. doi:10.2147/OTT.S492659. https://pubmed.ncbi.nlm.nih.gov/39717713/